M&A: Page 2

Intersect ENT stock jumps on report of potential Medtronic takeover

A Bloomberg report published late Tuesday said the medtech giant had made an offer for the sinusitis tech maker, citing people with knowledge of the matter. Shares in Intersect were up around 35% early Wednesday.

By Maria Rachal • July 08, 2020

UK raises red flags about Stryker's $4B bid for Wright Medical

The Competition and Markets Authority suggested the proposed acquisition would result in Stryker controlling 90% of Britain's total ankle replacement prostheses market.

By Greg Slabodkin • July 01, 2020

Invitae cash-and-stock buyout of ArcherDX a done deal

The medical genetic testing company swept in after the assay developer announced plans to go public. Invitae will now offer tests for more stages of cancer care, from assessing disease risk to monitoring its progression.

By Maria Rachal • UPDATED: Oct. 5, 2020 at 10:18 a.m.

Medtronic, Titan Medical ink robotics development, license agreements

The beleaguered robotic surgery company said Thursday it will receive up to $31 million from Medtronic's licensing of technologies. It's the medtech giant's second robotics deal this year as it works to launch its own soft tissue robot.   

By Greg Slabodkin • June 04, 2020

Haemonetics unveils back-to-back divestitures of blood supply assets

The company saw a 25% to 30% drop in April plasma collections and is now preserving cash, but Wall Street analysts see a few upcoming growth drivers.

By Nick Paul Taylor • June 04, 2020

J&J, Takeda cancel $400M surgical patch deal after antitrust scrutiny

U.S. and EU regulators raised concerns over lack of competition in the market for the fibrin sealant products meant to stop bleeding during surgery.

By Susan Kelly • April 13, 2020

OrthoPediatrics buys FDA-approved scoliosis tech, challenging Zimmer for market

OrthoPediatrics scooped up ApiFix's minimally invasive deformity correction system, an alternative to spinal fusion procedures and Zimmer Biomet's vertebral body tethering technology.

By Maria Rachal • April 02, 2020

Exact Sciences closes takeovers of 2 cancer testing businesses

The deals give the diagnostics company a solid tumor test and R&D capabilities as it aims to expand beyond its flagship Cologuard product.

By Nick Paul Taylor • March 04, 2020

After waffling, Qiagen agrees to $11.5B buyout by Thermo Fisher

Months of will-they-won't-they M&A rumors culminated in the Dutch test maker accepting an offer for a 23% premium on its shares, as Thermo Fisher aims to strengthen its molecular diagnostics and infectious disease efforts.

By Maria Rachal • March 03, 2020

Teleflex strikes $260M deal, gaining parts used in TAVR procedures

In releasing quarterly results, the Wayne, Pennsylvania-based medtech also gave updates on a new direct-to-consumer ad campaign and headwinds expected from the coronavirus outbreak.

By Nick Paul Taylor • Feb. 20, 2020

Private equity medical practice takeovers more than doubled from 2013 to 2016

Heart, eye and radiology medical practices were among the increasingly attractive targets, according to research published in JAMA.

By Samantha Liss • Feb. 19, 2020

Medtronic buys British surgical AI company, adding to Hugo robot effort

The acquisition of Digital Surgery comes as Medtronic inches its own soft tissue robot toward competition with Intuitive's da Vinci.

By Maria Rachal • Feb. 13, 2020

Intuitive buys IT startup for surgical video sharing, archiving, analysis

The acquisition of clinical video and image documentation company Orpheus Medical comes as big players like J&J and Medtronic are preparing to shake up the robotic surgery market. 

By Maria Rachal • Feb. 11, 2020

Qiagen, still independent, limps back from 2019

The Dutch maker of infectious disease instruments and consumables is seeking a rebound, with an early boost from coronavirus-driven demand. Cowen analysts noted the firm beat expectations but added: "The bar was quite low."

By Nick Paul Taylor • Feb. 05, 2020

Smith & Nephew acquires Tusker's PMA-winning ear infection device for ENT portfolio

The buyout of Tusker Medical comes two months after it won FDA premarket approval for an ear tube delivery system that can be used in young children with local anesthesia alone in a doctor's office.

By Maria Rachal • Jan. 24, 2020

Medical device sales flat, J&J CEO promises big year for robots

A Medical Device Business Review Day scheduled for this spring in New York City will feature "tangible evidence of not only the machines, but also the digital platform component," Alex Gorsky said of J&J's robotic surgery ventures.

By Nick Paul Taylor • UPDATED: Jan. 23, 2020 at 10:53 a.m.

Quest buys Helsinki-based Blueprint Genetics to expand reach

Blueprint Genetics sells 3,900 targeted single gene and more than 200 panel tests for conditions spanning 14 medical specialties. Financial terms of the all-cash equity deal were not disclosed.

By Rebecca Pifer • Jan. 22, 2020

Health IT to lead 2020 deals, KPMG predicts

The repeal of the medical device tax could boost investor interest in hot areas like non-invasive diagnostics, robotic surgery and AI-enabled devices, although health IT, pharma and biotech appear to be drawing more excitement.

By Linda Wilson • Jan. 15, 2020

LabCorp, Quest push for M&A-driven growth despite difficulties closing deals

“It’s still a very fragmented marketplace,” said Quest CEO Steve Rusckowski at JPM. "Trying to get people to move fast has been harder than I would have anticipated,” LabCorp's new CEO Adam Schechter told investors.

By Nick Paul Taylor • Jan. 15, 2020

RTI Surgical inks $490M deal to sell OEM unit to private equity

The divestiture will turn Michigan-based RTI into a pure play spine company with up to $200 million in cash, as private equity groups show growing interest in the medical technology sector.

By Nick Paul Taylor • Jan. 14, 2020

Medtronic buys new spinal cord tech to boost pain therapies unit

Amid a broader slowdown in the spinal cord stimulation market, Medtronic is acquiring technology from Stimgenics that offers a new way of programming its Intellis implant.

By Maria Rachal • Jan. 09, 2020

Digital health M&A flatlines in 2019, but IPO activity promising

Rock Health sees creation of remote patient monitoring reimbursement codes, progress on data blocking rules and FDA's Pre-Cert program as potential growth catalysts for the sector.

By Nick Paul Taylor • Jan. 08, 2020

OrthoPediatrics sells Vilex assets in preparation for more M&A

The device maker sold the adult piece of the Vilex business, which it acquired last year, for $25 million.

By Nick Paul Taylor • Jan. 07, 2020

Illumina scraps $1.2B PacBio takeover amid regulatory pushback

Cowen analysts listed Agilent, Danaher and Thermo Fisher as potential buyers of Pacific Biosciences.

By Nick Paul Taylor • Jan. 03, 2020

FTC slaps Stryker, Wright Medical with second request

In a second amendment to its tender offer statement for Wright Medical, Stryker acknowledged a Wright shareholder's class action lawsuit alleging Wright's solicitation statement was false and misleading.

By David Lim , Maria Rachal • UPDATED: Jan. 23, 2020 at 10:50 a.m.